65 related articles for article (PubMed ID: 26305602)
21. Aryl hydrocarbon receptor exogenous ligand 3-methylchoranthrene inhibited endometrial cancer cells proliferation.
Qu XL; Wang SY; Jia YJ; Guan Y
Eur Rev Med Pharmacol Sci; 2014; 18(8):1269-76. PubMed ID: 24817304
[TBL] [Abstract][Full Text] [Related]
22. Transcription factor Fli-1 expression by bone marrow cells in chronic myeloproliferative disorders is independent of an underlying JAK2 (V617F) mutation.
Bock O; Hussein K; Neusch M; Schlué J; Wiese B; Kreipe H
Eur J Haematol; 2006 Dec; 77(6):463-70. PubMed ID: 16930139
[TBL] [Abstract][Full Text] [Related]
23. High TRIM44 expression in endometrial carcinoma is associated with a poorer patient outcome.
Li P; Yin H; Meng F; Liu S; Liu H; Ma R
Pathol Res Pract; 2018 May; 214(5):727-731. PubMed ID: 29526558
[TBL] [Abstract][Full Text] [Related]
24. Fli-1, a Functional Factor Performed in Autoimmune Lupus.
Xu WD; Zhang M; Zhao Y; Liu Y
Inflammation; 2016 Feb; 39(1):493-498. PubMed ID: 26424096
[TBL] [Abstract][Full Text] [Related]
25. PELP1/MNAR suppression inhibits proliferation and metastasis of endometrial carcinoma cells.
Wan J; Li X
Oncol Rep; 2012 Dec; 28(6):2035-42. PubMed ID: 22992812
[TBL] [Abstract][Full Text] [Related]
26. MUC20 overexpression predicts poor prognosis and enhances EGF-induced malignant phenotypes via activation of the EGFR-STAT3 pathway in endometrial cancer.
Chen CH; Wang SW; Chen CW; Huang MR; Hung JS; Huang HC; Lin HH; Chen RJ; Shyu MK; Huang MC
Gynecol Oncol; 2013 Mar; 128(3):560-7. PubMed ID: 23262208
[TBL] [Abstract][Full Text] [Related]
27. Silencing of Cathepsin B suppresses the proliferation and invasion of endometrial cancer.
Bao W; Fan Q; Luo X; Cheng WW; Wang YD; Li ZN; Chen XL; Wu D
Oncol Rep; 2013 Aug; 30(2):723-30. PubMed ID: 23708264
[TBL] [Abstract][Full Text] [Related]
28. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
Hu WF; Liu MQ; Zhao Q
Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194
[TBL] [Abstract][Full Text] [Related]
29. miR-133a functions as a tumor suppressor and directly targets FSCN1 in pancreatic cancer.
Qin Y; Dang X; Li W; Ma Q
Oncol Res; 2013; 21(6):353-63. PubMed ID: 25198665
[TBL] [Abstract][Full Text] [Related]
30. The long non-coding RNA HOTAIR is upregulated in endometrial carcinoma and correlates with poor prognosis.
He X; Bao W; Li X; Chen Z; Che Q; Wang H; Wan XP
Int J Mol Med; 2014 Feb; 33(2):325-32. PubMed ID: 24285342
[TBL] [Abstract][Full Text] [Related]
31. EMX2 is downregulated in endometrial cancer and correlated with tumor progression.
Qiu H; Yan Q; Luo X; Zhang H; Bao W; Wan X
Int J Gynecol Pathol; 2013 Mar; 32(2):193-8. PubMed ID: 23370654
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
[TBL] [Abstract][Full Text] [Related]
33. Effects and mechanism of downregulation of COX‑2 expression by RNA interference on proliferation and apoptosis of human breast cancer MCF‑7 cells.
Han H; Yang S; Lin SG; Xu CS; Han ZH
Mol Med Rep; 2014 Dec; 10(6):3092-8. PubMed ID: 25323004
[TBL] [Abstract][Full Text] [Related]
34. The role of Fli-1 in normal cell function and malignant transformation.
Truong AH; Ben-David Y
Oncogene; 2000 Dec; 19(55):6482-9. PubMed ID: 11175364
[TBL] [Abstract][Full Text] [Related]
35. Activation of ERK1/2 occurs independently of KRAS or BRAF status in endometrial cancer and is associated with favorable prognosis.
Mizumoto Y; Kyo S; Mori N; Sakaguchi J; Ohno S; Maida Y; Hashimoto M; Takakura M; Inoue M
Cancer Sci; 2007 May; 98(5):652-8. PubMed ID: 17388789
[TBL] [Abstract][Full Text] [Related]
36. p21-activated kinase 4 regulation of endometrial cancer cell migration and invasion involves the ERK1/2 pathway mediated MMP-2 secretion.
Lu W; Xia YH; Qu JJ; He YY; Li BL; Lu C; Luo X; Wan XP
Neoplasma; 2013; 60(5):493-503. PubMed ID: 23790167
[TBL] [Abstract][Full Text] [Related]
37. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor.
Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D
Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin II promotes endometrial cancer cell survival.
Nowakowska M; Matysiak-Burzyńska Z; Kowalska K; Płuciennik E; Domińska K; Piastowska-Ciesielska AW
Oncol Rep; 2016 Aug; 36(2):1101-10. PubMed ID: 27349856
[TBL] [Abstract][Full Text] [Related]
39. Cyclooxygenase-2 and p53 expressions in endometrial cancer.
Jeon YT; Kang S; Kang DH; Yoo KY; Park IA; Bang YJ; Kim JW; Park NH; Kang SB; Lee HP; Song YS
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1538-42. PubMed ID: 15342458
[TBL] [Abstract][Full Text] [Related]
40. Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer.
Trovik J; Wik E; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; Njolstad TS; ; Vandenput I; Amant F; Akslen LA; Salvesen HB
Clin Cancer Res; 2011 May; 17(10):3368-77. PubMed ID: 21242118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
